The Epidemiology Department contributes to the mission of the institute through basic and applied epidemiological research on, but not limited to, malaria and other diseases of public health importance. It is also home to the Social Science Unit of the Institute, including the Health Support Centre for HIV/AIDS and other communicable and noncommunicable health problems. The Department hosts the Institute’s Clinical Trials Unit and has oversight of the Computer and Information Technology sections as well as a nascent Data Management facility. In view of its unique expertise and role, the Department provides technical assistance in studies of other researchers of the Institute in the areas of research design, implementation, and data management. Staff of the Department includes a mixed array of medical epidemiologists, health social scientists, clinicians, pharmacists, nurses, statisticians, laboratory technicians, etc.
The department has over the years led in several areas of research conducted by the Institute including the following:
• Child survival in the Gomoa District of the Central Region of Ghana
• Serological surveys for EPI vaccines
• Studies in the search for more effective EPI vaccines.
• Epidemiology of filariasis in the coastal region of the country
• Sociocultural aspects of filariasis in the coastal region of the country
• Immunoepidemiological studies of Malaria in southern Ghana.
• Sociocultural studies of malaria in southern Ghana
• Maternal Mortality Assessment studies
Currently, major research areas include several studies on malaria including;
• Clinical Epidemiology of Malaria (funded by the DMID /NIAIH / NIH and carried out in collaboration with the Navrongo Health Research Centre, Kintampo Health Research Centre and the Centre National pour Recherche er Formation sur Le Paludisme (CNRFP) in Ouagadougou, Burkina Faso;
• Monitoring of anti malarial drug efficacy in the treatment of uncomplicated malaria in Ghana.
• Sociocultural determinants of malaria in southern Ghana;
Other biomedical studies include
• Responses of patients with advanced breast cancer to neoadjuvant therapy (funded through a grant from the Mayo Clinic)
• Pharmacogenetics of estrogen metabolic pathway enzymes and breast cancer in women of African descent funded through a grant from the Roswell Park Cancer Institute.